Pharming Group NV (PHAR)
12.28
-0.31
(-2.46%)
USD |
NASDAQ |
Jun 10, 16:00
12.59
+0.31
(+2.52%)
After-Hours: 20:00
Pharming Group Total Assets (Quarterly) : 489.36M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 489.36M |
| December 31, 2025 | 510.44M |
| September 30, 2025 | 473.78M |
| June 30, 2025 | 446.26M |
| March 31, 2025 | 403.18M |
| December 31, 2024 | 411.36M |
| September 30, 2024 | 425.51M |
| June 30, 2024 | 415.93M |
| March 31, 2024 | 441.67M |
| December 31, 2023 | 470.96M |
| September 30, 2023 | 436.47M |
| June 30, 2023 | 429.80M |
| March 31, 2023 | 423.00M |
| December 31, 2022 | 432.04M |
| September 30, 2022 | 382.32M |
| June 30, 2022 | 393.90M |
| March 31, 2022 | 392.80M |
| December 31, 2021 | 403.12M |
| September 30, 2021 | 400.94M |
| June 30, 2021 | 411.84M |
| March 31, 2021 | 409.30M |
| December 31, 2020 | 418.79M |
| September 30, 2020 | 374.48M |
| June 30, 2020 | 356.16M |
| March 31, 2020 | 333.49M |
| Date | Value |
|---|---|
| December 31, 2019 | 258.80M |
| September 30, 2019 | 240.73M |
| June 30, 2019 | 234.36M |
| March 31, 2019 | 224.08M |
| December 31, 2018 | 245.28M |
| September 30, 2018 | 223.84M |
| June 30, 2018 | 211.76M |
| March 31, 2018 | 209.91M |
| December 31, 2017 | 199.56M |
| September 30, 2017 | 165.46M |
| June 30, 2017 | 144.81M |
| March 31, 2017 | 140.58M |
| December 31, 2016 | 133.72M |
| September 30, 2016 | 54.91M |
| June 30, 2016 | 59.62M |
| March 31, 2016 | 63.56M |
| December 31, 2015 | 62.65M |
| September 30, 2015 | 69.39M |
| June 30, 2015 | 55.89M |
| March 31, 2015 | 57.73M |
| December 31, 2014 | 67.42M |
| September 30, 2014 | 51.49M |
| June 30, 2014 | 56.13M |
| March 31, 2014 | 45.76M |
| December 31, 2013 | 43.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ProQR Therapeutics NV | 114.11M |
| NewAmsterdam Pharma Co. NV | 732.64M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alkermes Plc | 4.258B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 220.41M |
| Shareholders Equity (Quarterly) | 268.96M |
| Debt to Equity Ratio | 0.4321 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | -0.07% |